期刊文献+

CT增强程度对胰腺癌和炎性胰腺肿块的鉴别诊断价值 被引量:9

Value of CT enhancement degree in differential diagnosis between pancreatic carcinoma and inflammatory pancreatic mass
原文传递
导出
摘要 目的比较胰腺癌和炎性胰腺肿块的 CT 增强程度,研究胰腺各期的 CT 强化程度对该两种疾病的诊断价值。方法南京军区南京总医院85例胰腺癌和炎性胰腺肿块患者行平扫、胰期和延迟期增强扫描,测量胰腺肿块和正常胰腺组织的 CT 值,并进行统计学分析。结果 85例患者,胰腺癌66例,炎性胰腺肿块19例。在 CT 平扫、胰期增强、延迟期增强中,胰腺癌组肿块的 CT 值(HU)分别为34±7、54±10、61±14,其相对正常胰腺组织的 CT 值分别是42±6、105±12、77±10;炎性胰腺肿块的 CT 值分别是37±6、58±17、64±10,其相对正常胰腺组织的 CT 值分别是40±8、85±10、72±9。结论胰腺癌肿块和炎性胰腺肿块胰期增强 CT 值对两者的鉴别有一定局限;胰腺癌组和炎性胰腺肿块组肿块以外相对正常胰腺组织的胰期增强程度,前者强化明显,后者则强化中等。 Objective To compare the CT enhancement degree in pancreatic carcinoma (PC) and inflammatory pancreatic mass (IPM), and to study the diagnostic value of CT to these two diseases. Methods Eighty-five patients with PC or IPM, 47 males and 38 females, aged 62 (37-79), underwent plain CT scanning and enhanced CT scanning in pancreatic phase and delay phase. The CT values of the pancreatic mass and relative normal pancreatic tissue were measured. The diagnosis of PC and IPM was verified by operation, biopsy, etc. Sixty persons without pancreatic diseases were used as controls. Results Among the 85 patients, 66 were proved to be with PC,and 19 patients were proved to be with IPM. In plain CT scanning, pancreatic-phase CT enhancement, and delay-phase CT enhancement, the CT values of PC were(34±7) HU, (54 ± 10) HU, and (61 ± 14) HU respectively; and the CT values of the relatively normal pancreatic tissue were (42 ± 6) HU, ( 105 ± 12) HU, and (77 ± 10) HU respectively. In plain CT scanning, pancreatic-phase CT enhancement, and delay-phase CT enhancement, the CT values of IPM were (37±6) HU, (58 ± 17) HU, and (64 ± 10) HU respectively; and the CT values of the relatively normal pancreatic tissue were (40±8) HU, (85±10) HU, and (72±9) HU respectively. The pancreatic-phase enhanced CT values of the mass in the PC group and the IPM group showed no remarkable differences (P 〉 0.05). The pancreatic-phase enhancement intensity of the relatively normal pancreatic tissue is greater in PC than in IPM (P 〈 0.01 ). Conclusion There is a certain limit for CT enhancement in differentiating between PC and IPM. Comprehensive analysis is necessary in diagnosis of PC and IPM.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第16期1120-1122,共3页 National Medical Journal of China
基金 江苏省社会发展计划基金(BS2006053) 江苏省"六大高峰人才"基金(2005A2)
关键词 胰腺肿瘤 胰腺炎 体层摄影术 X线计算机 诊断 Pancreatic neoplasms Pancreatitis Tomography, X-ray computed Diagnosis
  • 相关文献

参考文献7

  • 1王中秋,黎介寿,卢光明,张新华.胰腺癌的CT增强和瘤体微血管密度及病理分级的相关性研究[J].中华医学杂志,2003,83(21):1882-1886. 被引量:29
  • 2邓瑞雪,陆星华,王丽,李辉,钱家鸣,杨爱明,钟守先,郭晓钟,周璐,吴晰,杨晓鸥,蒋卫君.建立医院胰腺癌高危评分模型及筛查方案的研究[J].中华医学杂志,2005,85(29):2038-2042. 被引量:11
  • 3张群华,倪泉兴,代表中国抗癌协会胰腺癌专业委员会.胰腺癌2340例临床病例分析[J].中华医学杂志,2004,84(3):214-218. 被引量:141
  • 4To'o KJ, Raman SS, Yu NC, et al. Pancreatic and peripancreatic diseases mimicking primary pancreatic neoplasia. Radiographics, 2005,25 : 949-965.
  • 5Mortele K J, Rocha TC, Streeter JL, et al. Multimodality imaging of pancreatic and biliary congenital, anomalies. Radiographics, 2006, 26: 715-731.
  • 6Ichikawa T, Sou H, Araki T, et al. Duct-penetrating sign at MRCP : usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology, 2001, 221:107-116.
  • 7Sahani D, Kadavigere R, Blake M, et al. Intraductal Papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations-correlation with MRCP. Radiology, 2006, 238:560-569.

二级参考文献28

  • 1Kasper HU, Ebert M, Malfertheiner P, et al. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density. Virchows Arch , 2001,438:116-120.
  • 2Bruns CJ, Harbison MT, Davis DW, et al. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res, 2000,6:1936-1948.
  • 3Bruns CJ, Solorzano CC, Harbison MT,et al. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res , 2000,60:2926-2935.
  • 4Seo Y, Baba H, Fukuda T, et al. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer, 2000,88:2239-2245.
  • 5Banerjee SK, Zoubine MN, Mullick M, et al. Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations. Pancreas , 2000,20:248-255.
  • 6Fujimoto K, Hosotani R, Wada M, et al. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis. Eur J Cancer, 1998,34:1439-1447.
  • 7Folkman J. Tumor angiogennesis: therapeutic implications. N Engl J Med,1971,285:1182-1186.
  • 8Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst,1990,82:4-6.
  • 9Folkman J. Fighting cancer by attacking its blood supply. Sci Am,1996,275:150-154.
  • 10Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1996,86:353-364.

共引文献174

同被引文献61

引证文献9

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部